Factor analysis of positive and negative syndrome scale in schizophrenia: An exploratory study

Indian Journal of Psychiatry

Volumn 54, Issue 3, 2012, Pages 233-238

  Kumar, Ajay ^a   Khess, C R J ^b  

^a POST GRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

^b CENTRAL INSTITUTE OF PSYCHIATRY   (India)

Author keywords

Factor analysis; positive and negative syndrome scale; schizophrenia

Indexed keywords

ADULT; ARTICLE; AUTISM; CONSENSUS; CONTROLLED STUDY; DEPRESSION; DISEASE EXACERBATION; EXPLORATORY RESEARCH; FACTORIAL ANALYSIS; FEMALE; HUMAN; INDIA; MAJOR CLINICAL STUDY; MALE; MEDICAL LITERATURE; POSITIVE AND NEGATIVE SYNDROME SCALE; SCHIZOPHRENIA;

EID: 84869997068     PISSN: 00195545     EISSN: 19983794     Source Type: Journal    
DOI: 10.4103/0019-5545.102419     Document Type: Article

References (33)

1. Crow TJ. Molecular pathology of schizophrenia; More than one disease process? BMJ 1980;280; 66-8.
2. Strauss JS, Carpenter WT Jr, Bartko JJ. The diagnosis and understanding of schizophrenia; II, Speculations on the processes that underlie schizophrenic symptoms and signs. Schizophr Bull 1974;11; 61-76.
3. Andreasen N. The Scale for the Assessment of Negative Symptoms (SANS). University of Iowa, Iowa City, IA: 1983.
4. Andreasen, N. The Scale for the Assessment of Positive Symptoms (SAPS). University of Iowa, Iowa City, IA: 1984.
5. Andreasen NC, Arndt S, Alliger R, Miller D, Flaum M. Symptoms of schizophrenia: Methods, meanings, and mechanisms. Arch Gen Psychiatry 1995;52; 341-51.
6. Kay SR, Fisbein A, Opler LA. The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophr Bull 1987;13; 261-76.
7. Overall J, Gorham D. Brief psychiatric rating scale. Psychol Rep 1962;10:799-812.
8. Singh MM, Kay SR. Therapeutic antagonism between anticholinergic antiparkinsonism agents and neuroleptics in schizophrenia. Implications for a neuropharmacological model. Neuropsychobiology 1979;5:74-86.
9. White L, Harvey PD, Opler L, Lindenmayer JP. Empirical assessment of the factorial structure of clinical symptoms in schizophrenia: A multisite, multimodel evaluation of the factorial structure of the Positive and Negative Syndrome Scale: The PANSS Study Group. Psychopathology 1997;30:263-74.
10. Kay SR, Opler LA, Fiszbein A. Positive and Negative Syndrome Scale (PANSS). Multi-Health Systems, Toronto: 2000.
11. Emsley RA, Rabinowitz J, Torreman M. The factor structure for the Positive and Negative Syndrome Scale (PANSS) in recent-onset psychosis. Schizophr Res 2003;61:47-57.
12. Lancon C, Reine G, Llorca PM, Auquier P. Validity and reliability of the French-language version of the Positive and Negative Syndrome Scale (PANSS). Acta Psychiatr Scand 1999;100; 237-43.
13. Lancon C, Auquier P, Nayt G, Reine G. Stability of the five-factor structure of the Positive and Negative Syndrome Scale (PANSS). Schizophr Res 2000;42; 231-9.
14. Fitzgerald PB, Williams CL, Corteling N, Filia SL, Brewer K, Adam, A, et al. Subject and observer-rated quality of life in schizophrenia. Acta Psychiatr Scand 2001;103:387-92.
15. Kulhara P, Kota SK, Joseph S. Positive and negative subtypes of schizophrenia; A study from India. Acta Psychiatr Scand 1986;74; 353-9.
16. Kulhara P, Chandiramani K. Positive and negative subtypes of schizophrenia: A follow-up study from India. Schizophr Res 1990;3; 107-16.
17. Field A. Discovering statistics using SPSS for window. London: Sage; 2000.
18. Stevens J. Applied multivariate statistics for the social sciences. In; Mahwah NJ, editor. 3rd ed. Laurence Erlbaum Associates; 1996.
19. De Geus F, Denys D. Pitfalls in factor analytic techniques. Am J Psychiatry 2004;161; 579-80.
20. Kota SK, Kulhara P. A clinical study of positive and negative subtypes of Schiozphrenia. Indian J Psychiatry 1988;30:255-36.
21. Karow A, Moritz S, Lambert M, Schoder S, Krausz M. PANSS syndromes and quality of life in schizophrenia. Psychopathology 2005;38; 320-6.
22. Andreasen NC, Grove WM. Evaluation of positive and negative symptoms in schizophrenia. Psychiatr Psychobiol 1986;2; 108-21.
23. Andreasen NC, Olsen S. Negative vs positive schizophrenia: Definition and validation. Arch Gen Psychiatry 1982;39; 789-94.
24. Peralta V, de Leon J, Cuesta MJ. Are there more than two syndromes in schizophrenia? A critique of the positive-negative dichotomy. Br J Psychiatry 1992;161; 335-43.
25. Peralta V, Cuesta MJ. How many and which are the psychopathological dimensions in schizophrenia? Issues influencing their ascertainment. Schizophr Res 2001;49; 269-85.
26. Kay SR, Sevy S. Pyramidical model of schizophrenia. Schizophr Bull 1990;16:537-45.
27. Marder SR, Davis JM, Chouinard G. The effects of risperidone on the five dimensions of schizophrenia derived by factor analysis: Combined results of the North American trials. J Clin Psychiatry 1997;58; 538-46.
28. Lykouras L, Oulis P, Psarros K, Daskalopoulou E, Botsis A, Christodoulou GN, et al. Five-factor model of schizophrenic pathology; How valid is it? Eur Arch Psychiatry Clin Neurosci 2000;250; 93-100.
29. Lindenmayer JP, Bernstein-Hyman R, Grochowski S. A new five factor model of schizophrenia. Psychiatr Q 1994;65; 299-322.
30. Kawasaki Y, Maeda Y, Sakai N, Higashima M, Urata K, Yamaguchi N, et al. Evaluation and interpretation of symptom structures in patients with schizophrenia. Acta Psychiatr Scand 1994;89; 399-404.
31. Lindenmayer JP, Grochowski S, Hyman RB. Five factor model of schizophrenia: Replication across samples. Schizophr Res 1995;14:229-34.
32. Lindenmayer JP, Bernstein-Hyman R, Grochowski S, Bark N. Psychopathology of schizophrenia; Initial validation of a 5-factor model. Psychopathology 1995;28; 22-31.
33. Arndt S, Alliger RJ, Andreasen NC. The distinction of positive and negative symptoms: The failure of a two-dimensional model. Br J Psychiatry 1991;158:317-22.